Department of Pharmacology and Personalized Medicine, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, 6229 ER Maastricht, The Netherlands.
Department of Neurology, University Hospital Würzburg, 97080 Würzburg, Germany.
Proc Natl Acad Sci U S A. 2017 Nov 14;114(46):12315-12320. doi: 10.1073/pnas.1705034114. Epub 2017 Oct 31.
Ischemic injury represents the most frequent cause of death and disability, and it remains unclear why, of all body organs, the brain is most sensitive to hypoxia. In many tissues, type 4 NADPH oxidase is induced upon ischemia or hypoxia, converting oxygen to reactive oxygen species. Here, we show in mouse models of ischemia in the heart, brain, and hindlimb that only in the brain does NADPH oxidase 4 (NOX4) lead to ischemic damage. We explain this distinct cellular distribution pattern through cell-specific knockouts. Endothelial NOX4 breaks down the BBB, while neuronal NOX4 leads to neuronal autotoxicity. Vascular smooth muscle NOX4, the common denominator of ischemia within all ischemic organs, played no apparent role. The direct neuroprotective potential of pharmacological NOX4 inhibition was confirmed in an ex vivo model, free of vascular and BBB components. Our results demonstrate that the heightened sensitivity of the brain to ischemic damage is due to an organ-specific role of NOX4 in blood-brain-barrier endothelial cells and neurons. This mechanism is conserved in at least two rodents and humans, making NOX4 a prime target for a first-in-class mechanism-based, cytoprotective therapy in the unmet high medical need indication of ischemic stroke.
缺血性损伤是导致死亡和残疾的最常见原因,但仍不清楚为什么在所有身体器官中,大脑对缺氧最为敏感。在许多组织中,4 型 NADPH 氧化酶在缺血或缺氧时被诱导,将氧气转化为活性氧。在这里,我们在心脏、大脑和后肢的缺血小鼠模型中表明,只有在大脑中,NADPH 氧化酶 4(NOX4)才会导致缺血性损伤。我们通过细胞特异性敲除解释了这种独特的细胞分布模式。内皮细胞的 NOX4 破坏血脑屏障,而神经元的 NOX4 导致神经元自毒性。血管平滑肌中的 NOX4 是所有缺血器官中共同的缺血因素,但没有明显作用。在没有血管和血脑屏障成分的离体模型中,NOX4 的药理学抑制的直接神经保护潜力得到了证实。我们的结果表明,大脑对缺血性损伤的敏感性增加是由于 NOX4 在血脑屏障内皮细胞和神经元中的特定器官作用所致。这种机制在至少两种啮齿动物和人类中是保守的,这使得 NOX4 成为一种针对缺血性中风这一未满足的高医疗需求适应症的、基于机制的、细胞保护治疗的首要靶点。